After a 2-year delay, the SUPPORT for Patients and Communities Act will require all controlled substances for Medicare Part D beneficiaries to be electronically prescribed beginning January 1, 2023. To learn more about this mandate, including requirements and exceptions, please visit the frequently asked questions on the Centers for Medicare & Medicaid services (CMS) website.
Electronic Prescribing for Controlled Substances (EPCS) has the potential to help reduce medication errors, prescription theft and forgery, and helps ensure prescriptions are securely transmitted from provider to retail or mail-order pharmacies. EPCS requires 2-factor authentication (2fa), which means at least 2 types of identification components are needed for access.
Quanum ePrescribing offered by Quest Diagnostics can help you meet current EPCS mandates. Our service enables you to manage prescriptions quickly and conveniently through Quanum Electronic Health Record (EHR), or it can be purchased separately for a low monthly fee.
To learn more about implementing EPCS, contact us.